<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="147">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04392141</url>
  </required_header>
  <id_info>
    <org_study_id>1399.062</org_study_id>
    <nct_id>NCT04392141</nct_id>
  </id_info>
  <brief_title>Colchicine Plus Phenolic Monoterpenes to Treat COVID-19</brief_title>
  <official_title>Application of Colchicine Plus Herbal Phenolic Monoterpene Fractions to Treat COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kermanshah University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kermanshah University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, defined cases of COVID-19 with mild, moderate or severe pneumonia will be
      treated with standard treatment regimens in combination with oral administration of
      Colchicine Plus Herbal phenolic monoterpene Fractions. Improvement in clinical, laboratory
      and radiological manifestations will be evaluated in treated patient compared to control
      group.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>up to 30 days</time_frame>
    <description>All cause of death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in patients clinical manifestation</measure>
    <time_frame>up to 30 days</time_frame>
    <description>Mild, Moderate or Severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>up to 30 days</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>up to 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lymphocyte count</measure>
    <time_frame>up to 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum lactate dehydrogenase</measure>
    <time_frame>up to 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum Interleukin-6</measure>
    <time_frame>up to 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>erythrocyte sedimentation rate</measure>
    <time_frame>up to 30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>standard Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Colchicine and Herbal Phenolic Monoterpene Fractions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard Treatment</intervention_name>
    <description>Standard Treatment for COVID-19 based on National Recommendations</description>
    <arm_group_label>standard Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions</intervention_name>
    <description>Colchicine plus a Herbal extraction containing a Phenolic Monoterpene Fractions will be added to standard treatment in patients with COVID-19.</description>
    <arm_group_label>Colchicine and Herbal Phenolic Monoterpene Fractions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Defined cases of COVID-19 based on laboratory and/or radiological and clinical
             manifestation

        Exclusion Criteria:

          -  Age &lt;10, Pregnancy, Sever kidney dysfunction, Previous history of allergy to
             Colchicine, not willing to sign informed consent form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Mostafaie, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ali Mostafaie, PhD</last_name>
    <phone>+98 83 34279923</phone>
    <email>ali_mostafaie@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yadollah Shakiba, MD, PhD</last_name>
    <email>yshakiba@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran</name>
      <address>
        <city>Kermanshah</city>
        <zip>083</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Mostafaie, PhD</last_name>
      <phone>+98 83 34279923</phone>
      <email>ali_mostafaie@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Ali Mostafaie, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Siavash Vaziri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alireza Janbakhsh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yadollah Shakiba, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Farid Najafi, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohammad H Zamanian, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ahmad Bagheri, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Farhad Abdali, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kavyan Fatahpour, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Nerlekar N, Beale A, Harper RW. Colchicine--a short history of an ancient drug. Med J Aust. 2014 Dec 11;201(11):687-8.</citation>
    <PMID>25495322</PMID>
  </results_reference>
  <results_reference>
    <citation>Larsson S, RÃ¸nsted N. Reviewing Colchicaceae alkaloids - perspectives of evolution on medicinal chemistry. Curr Top Med Chem. 2014;14(2):274-89. Review.</citation>
    <PMID>24359194</PMID>
  </results_reference>
  <results_reference>
    <citation>Slobodnick A, Shah B, Krasnokutsky S, Pillinger MH. Update on colchicine, 2017. Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i4-i11. doi: 10.1093/rheumatology/kex453. Review.</citation>
    <PMID>29272515</PMID>
  </results_reference>
  <results_reference>
    <citation>Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest. 1995 Aug;96(2):994-1002.</citation>
    <PMID>7543498</PMID>
  </results_reference>
  <results_reference>
    <citation>Umar S, Shah MAA, Munir MT, Yaqoob M, Fiaz M, Anjum S, Kaboudi K, Bouzouaia M, Younus M, Nisa Q, Iqbal M, Umar W. Synergistic effects of thymoquinone and curcumin on immune response and anti-viral activity against avian influenza virus (H9N2) in turkeys. Poult Sci. 2016 Jul 1;95(7):1513-1520. doi: 10.3382/ps/pew069. Epub 2016 Mar 4.</citation>
    <PMID>26944958</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu QF, Wang W, Dai XY, Wang ZY, Shen ZH, Ying HZ, Yu CH. Chemical compositions and anti-influenza activities of essential oils from Mosla dianthera. J Ethnopharmacol. 2012 Jan 31;139(2):668-71. doi: 10.1016/j.jep.2011.11.056. Epub 2011 Dec 16.</citation>
    <PMID>22193174</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 15, 2020</study_first_submitted>
  <study_first_submitted_qc>May 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2020</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kermanshah University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Dr. Ali Mostafaie, PhD</investigator_full_name>
    <investigator_title>Professor of Immunology</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Colchicine</keyword>
  <keyword>Phenolic Monoterpenes</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colchicine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

